Real-life experience with dupilumab in 56 children and adolescents aged 2 to 17 with uncontrolled moderate-to-severe atopic dermatitis
- PMID: 39495495
- DOI: 10.23736/S2784-8671.24.07940-4
Real-life experience with dupilumab in 56 children and adolescents aged 2 to 17 with uncontrolled moderate-to-severe atopic dermatitis
LinkOut - more resources
Full Text Sources
